Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani.
Ontology highlight
ABSTRACT: Visceral leishmaniasis (VL) is associated with treatment complications due to the continued growth of resistant parasites toward currently available pathogen-directed therapeutics. To limit the emergence and combat resistant parasites there is a need to develop new anti-leishmanial drugs and alternative treatment approaches, such as host-directed therapeutics (HDTs). Discovery of new anti-leishmanial drugs including HDTs requires suitable in vitro assay systems. Herein, we modified and evaluated a series of resazurin assays against different life-stages of the VL causing parasite, Leishmania donovani to identify novel HDTs. We further analyzed the synergy of combinatorial interactions between traditionally used pathogen-directed drugs and HDTs for clearance of intracellular L. donovani. Th
SUBMITTER: Zahid MSH
PROVIDER: S-EPMC6731340 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA